Social cognition four years after mild-TBI: An age-matched prospective longitudinal cohort study.


Journal

Neuropsychology
ISSN: 1931-1559
Titre abrégé: Neuropsychology
Pays: United States
ID NLM: 8904467

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 29 3 2019
medline: 13 7 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

To assess longer-term social cognition after mild traumatic brain injury (mTBI) and to identify the sociodemographic and acute factors (mood, cognitive functioning, and symptoms) influencing social cognition. Data were extracted for 121 adults who experienced a mTBI and completed the Emotion Evaluation and Social Inference Enriched tests of The Awareness of Social Inference Test (TASIT) 4 years postinjury. To identify early indicators of outcome, responses to the Hospital Anxiety and Depression Scale, Rivermead Post-Concussion Symptom Questionnaire, and CNS Vital Signs neurocognitive assessment conducted 1 month postinjury were also extracted. Social cognition scores were compared to age-matched TASIT norms (N = 121). The mTBI group was significantly less able to interpret what people say and intend than norms, although the effect sizes were small (d = 0.43). There were 24.8% of people 4 years postmTBI and 9.9% of norms who experienced at least mild impairment in social inference. There were no significant differences between the mTBI group and norms for emotion evaluation. Poorer social inference 4 years after mTBI was significantly associated with lower cognitive flexibility and executive function (F = 2.57, df = 13,26, p = .02). Group differences remained after controlling for cognitive functioning (F = 104.59 df = 1,58, p = .001. These novel results suggest that adults postmTBI may experience social inference difficulties 4 years post-TBI that are not completely explained by cognitive difficulties. Further research is needed. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 30920237
pii: 2019-16888-001
doi: 10.1037/neu0000516
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

560-567

Subventions

Organisme : Health Research Council of New Zealand

Auteurs

Skye McDonald (S)

School of Psychology, University of New South Wales.

Nicola Starkey (N)

Department of Psychology, University of Waikato.

Suzanne Barker-Collo (S)

School of Psychology, University of Auckland.

Kelly M Jones (KM)

National Institute for Stroke and Applied Neuroscience, Auckland University of Technology.

Shanthi Ameratunga (S)

School of Population Health, University of Auckland.

Emily Wilson (E)

School of Psychology, University of New South Wales.

Valery L Feigin (VL)

National Institute for Stroke and Applied Neuroscience, Auckland University of Technology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH